A B S T R A C T The interactions ofadrenergic agonists and thyroid hormones on the growth of erythroid colony-forming units were studied in cultures of dog marrow before and after the establishment of hypothyroidism. Erythroid colony growth in cultures from euthyroid dogs was enhanced by isoproterenol and other adrenergic agonists having ,2-receptor specificity. With hypothyroidism, however, this responsiveness was lost, and sensitivity to a-agonists, such as phenylephrine and norepinephrine, was acquired. This alteration in receptor specificity appeared to be dependent upon thyroid hormone and was rapidly reversible. Preincubation of marrow cells from hypothyroid animals with thyroid hormone resulted in the reappearance ofresponsiveness to f-adrenergic agonists and the loss of sensitivity to a-agonists. These findings are in agreement with previous suggestions that,-adrenergic receptor activity is modulated by thyroid hormone levels and demonstrate that the specificity of adrenergic modulations of erythropoiesis in culture may accurately reflect the thyroid status of the intact animal.
INTRODUCTION
The growth and function of a number of cellular systems are influenced through interactions ofdifferent hormones and small molecules (1, 2) . Several studies have shown that a variety of hormones, incapable of initiating a differentiative event or metabolic function by themselves, have the capacity to enhance the effect of primary regulatory hormones. As an example, This study was presented in part at The 20th Annual Meeting of the American Society of Hematology, San Diego, Calif., 6 December 1977, and was published in abstract form in 1977. Blood. 50(Suppl. 1): 135.
Received for publication 2 October 1978 and in revised form 15 March 1979. dibutyryl cyclic AMP (db-cAMP)' enhances the induction of tyrosine aminotransferase in cultured hepatoma cells, but only in the presence of, or after preconditioning of, the cells by a glucocorticoid such as dexamethasone (3) .
Recent work from our laboratory, employing the in vitro growth of erythroid colony-forming cells, has shown that cAMP and related compounds enhance the growth of such colonies in marrow cell cultures from a variety of mammalian species (4) . In a manner similar to other reported interactions, however, the cyclic nucleotides were incapable of initiating colony growth by themselves, and erythropoietin (ESF) was a necessary constituent ofthe culture medium. In addition to cAMP, a number of compounds have been shown to influence in vitro erythroid colony formation, including p-adrenergic agonists (5) , thyroid hormones (6, 7) , growth hormone (8) , and various classes of steroid hormones (9) . Although these observations are of interest, the relationships of in vitro modulation of erythropoiesis to the in vivo regulation of erythrocyte production is not clear. In addition, a basic question exists as to whether such interactions, defined in culture, in any way reflect the hormonal state of the intact animal.
To investigate the influence of the in vivo endocrine state on erythroid colony growth, the erythropoietic effects of thyroid hormones and adrenergic agonists have been compared in marrow cultures from euthyroid and hypothyroid dogs. These two modulators have been shown to enhance erythroid colony growth from normal dog marrow via receptors which appear to have similar properties (6) . The results of these studies demonstrate that the responsiveness in culture to IAbbreviations used in this paper: db-cAMP, dibutyryl cyclic AMP; ESF, erythropoietin; T3, triiodothyronine; T4, thyroxine; TRIAC, triiodothyroacetic acid; TSH, thyroidstimulating hormone. 
Louis, Nlo.), and triiodothyroacetic acid (TRIAC) (K and K Laboratories, IInc., Plainview, N. Y.) wvere tested by adding these compounds in varying concentrations to appropriate cultures. L-T4 and TRIAC were dissolved in 70% ethanol with 1 N NaOH, and L-T3 was dissolved in 95% ethanol wvith 2 N HCI. These compounds were initially dissolved at a concentration of 10 mM. The remaining compounds were initially dissolved in alpha medium (Microbiological Associates, Walkersville, Md.), and all compounds were stubse(luently diluted in Hank's balanced salt solution and tested over a range of concentrations (0.1 mM -1.0 nM). Before the addition of thyroid hormones, the concentrations of L-T4 and L-T3 were 0.036 ,tmol and 0.38 nmol, respectively, in 1 ml of medium plus serum.
To examine the interaction of thyroid hormones and ,B-adrenergic agonists, the following antagonists (with their relative receptor specificities) were studied: propranolol (Plf2), butoxamine (p2), phentolamine (a) (all from Sigma Chemical Co.), and practolol (,8,) (Ayerst Laboratories, Montreal, Canada). In addition, the general adenyl cyclase stimulator, cholera enterotoxin, the phophodiesterase inhibitor, RO-20-1724 (Roche Diagnostics Div., Hoffman-LaRoche, Inc., Nutley, N. J.), and db-cAMP (Sigma Chemical Co.) were also tested.
RESULTS
Study animals. The serum T3, T4, and TSH levels of the four dogs before and after administration of 1311 are shown in Table I . Base-line T4 levels were all > 1.5 ,ug/dl, and TSH levels were all <2.5 IU. 3-4 mo after receiving 10 mCi of 1311, T4 levels were all <0.5 ,ug/dl, and TSH levels were all > 14.0 IU, confirming the hypothyroid state. In each instance, thyroid hormone values were reduced, and TSH levels rose and remained elevated after isotopic thyroid ablation.
Horm1onal effects otn in vitro colony grow;th. Thyroid hormone and its analogues consistently enhanced erythroid colony formation whether added to cultures of marrow cells obtained from euthyroid or hypothyroid dogs. The peak enhancement of colony growth depended upon both the concentration of thyroid hormone and the endocrine state of the animal. Whereas the optimal concentration for the L-T4 effect in cultures from euthyroid animals was 0.1 ,mol, the optimal concentration was 1.0 ,umol in cultures from hypothyroid animals. Fig. 1 specific for the adrenergic receptors linked to adenylate cyclase or whether there was a more general disturbance of the adenylate cyclase-cAMP system, several other compounds were studied. most effective concentrations are shown, although each compound was active in a concentration-dependent manner. These results imply that the loss of sensitivity of the erythroid colony-forming unit to isoproterenol is a result of altered a-agonist receptor function which is specific for the adenylate cyclase linked to the catechol receptor.
The af,3-agonist, norepinephrine, fails to enhance erythroid colony growth in marrow cells from euthyroid animals (5) . As shown in Fig. 4 is an a-receptor. A similar lack of effectiveness of the p1-antagonist, practolol, and the ,82-blocker, butoxamine, was also observed (data not shown).
Further confirmation of the presence of an a-receptor on erythroid colony-forming units from hypothyroid animals was provided by examining the effect of the a-agonist, phenylephrine. Although this compound is ineffective in cultures of marrow from euthyroid animals, it enhances erythroid proliferation in cultures from hypothyroid animals, with optimal activity at 0.1 ,tM, as shown in Fig. 6 . Additional evidence for the specificity of the receptor was indicated by complete inhibition of the phenylephrine effect by 1.0 nmol of phentolamine.
The hypothesis that the hypothyroid state somehow induces the conversion of f8-to a-adrenergic receptors was evaluated by incubating marrow cells from hypothyroid dogs for 30 min in the presence of 0.1 ,umol of L-T4. Fig. 7 shows the results of such an experiment. The preincubation in the presence of thyroid hormone resulted in the reappearance of responsiveness to the 13-agonist, isoproterenol, and loss of the previously observed responsiveness to the a-agonist, norepinephrine. Control suspensions of marrow cells without added thyroid hormone showed the pattern of agonist enhancement expected for cultures from hypothyroid animals (Figs. 2 and 4 ).
DISCUSSION
Although ESF is the primary regulator of erythropoiesis, various other hormones influence the prolifera- tion of erythrocyte precursors (13 (6) .
In addition, several observations were made which suggested that at least part of the influence of thyroid hormones in this setting was mediated by cell receptors having the properties of receptors for adrenergic agonists (6) . Thus, thyroid hormones enhanced the growth of erythroid colonies in a population of cells which, by velocity sedimentation analysis, was identical to cells whose growth was enhanced by isoproterenol. In confirmation, the thyroid hormone effect was completely abolished by the active stereoisomer of propranolol, although a higher concentration was required for blockade than was necessary to block the effect of isoproterenol.
Several lines of evidence indicate that thyroid hormone status may determine the response of an end organ or tissue to adrenergic stimulation. In hypothyroid animals, ,8-adrenergic responsiveness is reduced or absent (14) . In hypothyroidism in man, clinical evaluation suggests reduced adrenergic responsiveness as well (15) . Kunos Thus, the clinical and laboratory observations of decreased f8-and enhanced a-adrenergic activity in hypothyroidism are paralleled by changes in receptor activity on erythroid colony-forming units. These results suggest that the altered responses to catecholamines and thyroid hormones in vitro reflect the thyroid state of the intact animal and suggest a physiologic role for such modulators in erythropoiesis.
